Search Article 
 
Advanced search 
Official publication of the American Biodontics Society and the Center for Research and Education in Technology
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL RESEARCH
Year : 2019  |  Volume : 10  |  Issue : 4  |  Page : 97-102

Evaluation of Platelet Rich Fibrin in the Management of Gingival Recession Type I/II by Miller: A Randomized Clinical Split Mouth Study


Department of Periodontology, Dental Faculty, Damascus University, Damascus, Syria

Correspondence Address:
Mueataz Al-Qershi
Department of Periodontology, Dental Faculty, Damascus University, Al-Mazzeh, Damascus
Syria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/denthyp.denthyp_79_19

Rights and Permissions

Introduction: The ultimate goal of mucogingival plastic surgery is to obtain complete root coverage and an optimal appearance. The aim of this study was to evaluate the efficacy of platelet-rich fibrin (PRF) with coronally advanced flap (CAF) compared to connective tissue graft (CTG) with CAF in the treatment of gingival recession (GR). Material and Methods: A total of 20 patients were included in this randomized clinical study, presenting 40 GR Miller type I/II. The GR sides of patients were assigned randomly into test group (PRF + CAF) and control group (CTG + CAF). Clinical parameters, such as GR, probing depth (PD), clinical attachment level (CAL), and width of keratinized gingiva (WKG), were evaluated at baseline and 12 months later. Root coverage (RC %) and complete root coverage (CRC %) were assessed at 12 months post surgically. Statistical analysis was performed using paired, independent t-test and Mann–Whitney U test. Statistical significance was set at 0.05. Results: At 12 months the mean (SD) GR was 0.20 ± 0.50 mm for test group and 0.05 ± 0.15 mm for control group, whereas the mean RC% was 95.32 ± 11.92 for PRF + CAF and 98.61 ± 4.37 for CTG + CAF. CRC was obtained in CTG + CAF with 90% and with 80% in PRF + CAF. CAL gain was 2.80 ± 0.28 mm and 2.49 ± 0.55 mm in test and control sites, respectively. The gain of WKG was 1.31 ± 0.45 mm and 1.85 ± 0.25 mm in test and control sites, respectively. All the values were not significantly different (P ≥ 0.05). Conclusion: Using of PRF + CAF in the treatment of GR is a successful and effective treatment option and could serve as an alternative to CTGs.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed477    
    Printed50    
    Emailed0    
    PDF Downloaded98    
    Comments [Add]    

Recommend this journal